Middle
Selected Science News Highlights of 2018
As 2019 approaches, NIAID reflects on a productive year of allergic, immunologic, autoimmune and infectious disease research advances. View a slideshow highlighting selected NIAID science news from 2018.
Middle
Ebola Treatment Trial Begins in the DRC
A randomized, controlled Phase 2/3 trial testing multiple investigational Ebola therapies is enrolling patients with Ebola in the Democratic Republic of the Congo.
Middle
NIAID Now Blog
Read about NIAID research advances and resources on the NIAID Now blog.
